The cellular modification design and development of cell therapy drugs are in the early stages, covering several key aspects. These include the discovery of single-chain antibodies (scFv), the properties of functional components, and the methods of introducing these components into cells. These are crucial for ensuring the safety, specificity, and functionality of the product.
Immunization
Animal immunization is an early stage in drug development, and high-quality immunization antigen proteins are crucial for immunization success.
- CAR Target Proteins
- MHC-peptide Complex & Custom Service
Antibody Screening
Screening high-quality single-chain antibody (scFv) candidates can significantly increase the probability of successful development of cell therapy drugs.
- CAR Target Proteins
- Biotin-labeled CAR Targets
- MHC-peptide Complex
Vector Construction
Viral vectors are a critical part of genetically modifying immune cells to express CAR receptors and maximize cell therapy efficacy.
- GENPower CRISPR/Cas Enzymes
- GENIUS™Nuclease
Modification Detection
The successful expression of CAR/TCR provides a robust signal for the subsequent CMC (Chemistry, Manufacturing, and Controls) stage of translation, requiring complementary detection tools for confirmation.
- CAR Proteins for CAR Express Detection
- MHC-peptide Complex for TCR Express Detection